甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法)

ELISA Kit for Parathyroid Hormone Related Protein (PTHrP)

PTHLH; HHM; PTHR; PLP; Osteostatin; Parathyroid Hormone Like Hormone

  • 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法)实验结果图
  • CEA819Ra.jpg标准曲线图
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测甲状旁腺激素相关蛋白(PTHrP),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的甲状旁腺激素相关蛋白(PTHrP)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。

样本回收率范围(%)平均回收率(%)
serum(n=5)78-9083
EDTA plasma(n=5)78-8882
heparin plasma(n=5)79-9693

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%

线性

在定值血清及血浆样本内加入适量的甲状旁腺激素相关蛋白(PTHrP),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中甲状旁腺激素相关蛋白(PTHrP)含量的测定值与理论值的比率。

样本1:21:41:81:16
serum(n=5)86-103%79-96%80-91%83-93%
EDTA plasma(n=5)78-103%94-105%83-95%99-105%
heparin plasma(n=5)92-99%87-98%88-102%95-103%

稳定性

经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)50µL,
    加入50µL检测液A(临用前配制);
    37°C温育1小时。
3. 洗板3次;
4. 加检测溶液B100µL,37°C孵育30分钟;
5. 洗板5次;
6. 加TMB底物90µL,37°C孵育10-20分钟;
7. 加终止液50µL,立即450nm读数。

实验原理

本试剂盒应用竞争抑制酶联免疫分析法测定标本中待测物质水平。将甲状旁腺激素相关蛋白(PTHrP)单克隆抗体包被微孔板,制成固相载体,往包被抗体的微孔中同时加入生物素标记的抗原和待测抗原(标准品或样本),待测抗原与生物素标记抗原对特异性抗体进行竞争结合。温育后经洗涤去掉未结合物,然后加入HRP标记的亲和素,经过温育和彻底洗涤后加入底物TMB显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。待测标本浓度越高,标记抗原和抗体的结合就越受到抑制,显色愈浅。显色的深浅与酶量呈正相关,而与样品中待测物质含量呈负相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。

相关产品

编号适用物种:Rattus norvegicus (Rat,大鼠)应用(仅供研究使用,不用于临床诊断!)
RPA819Ra01甲状旁腺激素相关蛋白(PTHrP)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
CPA819Ra21甲状旁腺激素相关蛋白(PTHrP)卵白蛋白偶联物Immunogen; SDS-PAGE; WB.
CPA819Ra22甲状旁腺激素相关蛋白(PTHrP)卵白蛋白偶联物Immunogen; SDS-PAGE; WB.
CPA819Ra31甲状旁腺激素相关蛋白(PTHrP)钥孔血蓝蛋白偶联物Immunogen; SDS-PAGE; WB.
PAA819Ra01甲状旁腺激素相关蛋白(PTHrP)多克隆抗体WB; IHC; ICC; IP.
PAA819Ra08甲状旁腺激素相关蛋白(PTHrP)多克隆抗体WB; IHC; ICC; IP.
LAA819Ra71甲状旁腺激素相关蛋白(PTHrP)多克隆抗体(生物素标记)WB; IHC; ICC.
LAA819Ra81甲状旁腺激素相关蛋白(PTHrP)多克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
MAA819Ra24甲状旁腺激素相关蛋白(PTHrP)单克隆抗体WB; IHC; ICC; IP.
MAA819Ra21甲状旁腺激素相关蛋白(PTHrP)单克隆抗体WB; IHC
MAA819Ra22甲状旁腺激素相关蛋白(PTHrP)单克隆抗体WB; IHC; ICC; IP.
MAA819Ra23甲状旁腺激素相关蛋白(PTHrP)单克隆抗体WB
SEA819Ra甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
CEA819Ra甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA819Ra甲状旁腺激素相关蛋白(PTHrP)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.
KSA819Ra11甲状旁腺激素相关蛋白(PTHrP)检测试剂盒DIY材料(酶联免疫吸附试验法)Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志参考文献
Clinical and Experimental MetastasisCharacterization of a new renal cell carcinoma bone metastasis mouse model[PubMed: 20443133]
Stem Cells and DevelopmentTemporal activation of β-catenin signaling in the chondrogenic process of mesenchymal stem cells affects the phenotype of the cartilage generated.[PubMed: 22133004]
International journal of biological sciencesPTHrP Expression in Human MDA-MB-231 Breast Cancer Cells Is Critical for Tumor Growth and Survival and Osteoblast Inhibition[PubMed: PMC3753447]
Investigational New DrugsTetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts[Pubmed: 23673814]
Toxicology and Applied PharmacologyBetulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment[Pubmed:24463094]
Arch Gynecol Obstet.Calcitonin gene-and parathyroid hormone-related peptides in normotensive and preeclamptic pregnancies: a nested case–control study[Pubmed:24943060]
PLoS One15-Deoxy-Δ12, 14-Prostaglandin J2 Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss[PubMed: 25859665]
EndocrinologyA role for the calcitonin receptor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis[PubMed: 26135836]
Tumour Biol Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation.[Pubmed:27312487]
35Hedgehog signaling in bone regulates whole-body energy metabolism through a bone–adipose endocrine relay mediated by PTHrP and adiponectin[pubmed:27740628]
BoneLactation induces increases in the RANK/RANKL/OPG system in maxillary bone[Pubmed:29382610]
International Journal of Molecular SciencesA Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice[Pubmed: 31600911]
Journal of Orthopaedic Surgery and ResearchIdentification of a potential gene target for osteoarthritis based on bioinformatics analyses[Pubmed: 32571421]
International ImmunopharmacologyParathyroid hormone related protein (PTHrP)-mediated hypercalcemia in malignancy associated with anti-PD-1 immune checkpoint inhibitor treatment and related …[]
Паратиреоидный гормон-родственный протеин как предиктор развития мочекаменной болезни[]
Cell Death DisExtracellular vesicles-released parathyroid hormone-related protein from Lewis lung carcinoma induces lipolysis and adipose tissue browning in cancer ¡­[33510128]
Sci RepEffects of whole-body vibration training in a cachectic C26 mouse model[34732809]
Acta PhysiologicaThe acute adaptation of renal phosphate transporters in the murine kidney to oral phosphate intake requires multiple signals[Pubmed:35334154]